{[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl}amine trifluoroacetate, 95.0%, 5g

Balance de précision série PLJ-A Modèles non certifiés, 0,01 g, 6200 g, PLJ 6200-2A

(S)-2-Amino-4-bromobutanoic acid hydrobromide, 95.0%, 250mg

(S)-7-Amino-5-methyl-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride, 95%, 25mg

2-Chloro-N-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 1g

5,5-Dimethyl-2-(4-nitrophenyl)-1,3,2-dioxaborinane, 95.0%, 5g

(2S,3R,4S,5S,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 98%, 5g

METHYL 6,6-DIFLUOROBICYCLO[3.1.0]HEXANE-3-CARBOXYLATE, 95.0%, 1g

5-Chloro-2-nitroaniline>99.0%(GC)250g

L-Alanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-[[(4-methoxyphenyl)methyl]seleno]-, 98%, 100mg

4-(3-Fluoro-phenylsulfanylmethyl)-piperidine hydrochloride, 95.0%, 250mg

(4-Vinylphenyl)methanol, 95.0%, 5g

4-Fluoro-3,5-dimethylbenzonitrile, 98.0%, 100g